<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813603</url>
  </required_header>
  <id_info>
    <org_study_id>EBUS19VS22</org_study_id>
    <nct_id>NCT02813603</nct_id>
  </id_info>
  <brief_title>Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA</brief_title>
  <official_title>Comparison of the Diagnostic Yield Between Various Endobronchial Ultrasound-guided-transbronchial Needles (EBUS-TBN) to Evaluate Suspect Mediastinal and Hilar Lymph Nodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Zürich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators intend to compare the 19-gauge needle and the 22-gauge-needle during EBUS-TBNA
      concerning the diagnostic yield, the quality and quantity of each biopsy needle without
      raising the rate of complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators intend to compare the 19-gauge needle and the 22-gauge-needle during EBUS-TBNA
      performed in rigid bronchoscopy for patients with probable lung cancer diagnosis and enlarged
      mediastinal lymph nodes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity, specificity, accuracy</measure>
    <time_frame>February 2017</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of tumor cells and lymphocytes within 10 HPF</measure>
    <time_frame>February 2017</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>The number of complications like bleeding, infections, pneumothorax and pain</measure>
    <time_frame>February 2017</time_frame>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Study Product (19-gauge)</arm_group_label>
    <description>After randomization, the subject undergo EBUS-TBNA either with the 19-gauge needle or the 22-gauge needle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Intervention (22-gauge)</arm_group_label>
    <description>After randomization, the subject undergo EBUS-TBNA either with the 19-gauge needle or the 22-gauge needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBUS</intervention_name>
    <description>19G and 22G EBUS needles are compared in a randomized prospective way in lung cancer patients with enlarged mediastinal lymph nodes.</description>
    <arm_group_label>Study Product (19-gauge)</arm_group_label>
    <arm_group_label>Control Intervention (22-gauge)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        100 Patients with lung cancer and enlarged lymph nodes will be included in this study
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patients aged over 18

          -  Patients signed written informed consent

          -  Mediastinal or hilar enlarged lymph nodes (&gt;10mm) in short axis radiological or
             clinical findings likely for lung cancer

        Exclusion Criteria:

          -  Severe impairment of any organs, with do not enable anaesthesia

          -  Quick &lt;80%, INR &gt;1,5, thrombocytes &lt;50/nl or PTT&gt;120sec

          -  Other clinically relevant medical or psychological diseases, which affect the patients
             judgement or ability to participate in this study.

          -  Insufficient language ability (spoken and written German)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaid Darwiche, PD Dr. med.</last_name>
    <role>Study Director</role>
    <affiliation>supervising doctor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Celina Wolters, cand. med.</last_name>
    <email>celina.wolters@uk-essen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Filiz Özkan, Dr. med.</last_name>
    <email>filiz.oezkan@ruhrlandklinik.uk-essen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ruhrlandklinik, University Hospital Essen</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filiz Özkan, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Zürich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Franzen, Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>June 22, 2016</last_update_submitted>
  <last_update_submitted_qc>June 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Kaid Darwiche</investigator_full_name>
    <investigator_title>Priv. Doz. Dr. med. Kaid Darwiche</investigator_title>
  </responsible_party>
  <keyword>EBUS-TBNA</keyword>
  <keyword>staging</keyword>
  <keyword>lymph node metastases</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

